Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

Conditions: Chronic Obstructive Pulmonary Disease Interventions: Drug: Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg; Drug: Comparator - Trimbow ® Sponsors: Eurofarma Laboratorios S.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials